When the Game Changes

Over the past few months, the novel coronavirus disease 2019 (COVID-19) pandemic has posed many challenges for practicing physicians. Patients with sarcoidosis may have an increased risk of a poor outcome and death from COVID-19 infection for several reasons. First, sarcoidosis involves the lung in approximately 90% of patients,1 many of whom have diminished baseline lung function with reduced…

Read the full article here

Related Articles